Src Reduces Neutrophil Extracellular Traps Generation and Resolves Acute Organ Damage.

Area of Science:

• Immunology
• Molecular Biology
• Pathology

Background:

• Neutrophil extracellular traps (NETs) are implicated in acute inflammatory injury.
• The precise mechanisms governing NET formation and potential therapeutic targets are not fully understood.
• Emerging evidence suggests a role for Src kinase in regulating NETs.

Purpose of the Study:

• To investigate the role of Src kinase in NET formation and acute inflammatory injury.
• To elucidate the molecular mechanisms by which Src influences NETs.
• To evaluate Src inhibition as a potential therapeutic strategy for acute organ injury.

Main Methods:

• Activation of Src in in vitro NET models and human/murine neutrophils from pancreatitis and sepsis patients.
• Analysis of p-Src expression correlation with clinical prognosis.
• Inhibition of Src activity via gene silencing and pharmacological inhibitors.
• Investigation of Src-mediated signaling pathways (RAF/MEK/ERK, ROS production, PKC phosphorylation).
• Assessment of neutrophil-specific Src-deficient mice in vivo models of acute inflammation and organ damage.

Main Results:

• Src kinase is activated in NETs models, human/murine neutrophils, and correlates with patient prognosis.
• Src inhibition (gene silencing or inhibitors) significantly reduces NET formation in vitro.
• Src directly activates RAF1 and the RAF/MEK/ERK pathway, impacting ROS production and mediated by PKC phosphorylation.
• Neutrophil-specific Src deficiency ameliorates acute inflammatory response, organ damage, and NET formation in vivo.
• Src inhibitors demonstrate pharmacological efficacy in vivo.

Conclusions:

• Src is a critical mediator of intracellular ROS production, NET formation, and acute organ injury.
• Targeting Src kinase represents a potential therapeutic avenue for managing acute inflammatory conditions and organ damage.